Global X Genomics & Biotechnology ETF Rating $58.25 -0.81 (-1.37%) As of 01:45 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.61Holdings in GNOM have an aggregate rating of Moderate Buy based on 419 analyst ratings issued in the past year covering 24 companies (80.9% of the portfolio).GNOM Aggregate Price Target$58.14High Prediction$58.14Average Prediction$58.14Low Prediction$58.14Holdings in GNOM have an aggregate price target of $58.14 and a range of $58.14 to $58.14 covering 24 companies (80.9% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 GNOM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.19%GHGuardant Health$157.02-1.6%3.2527 of 5 stars2.96$183.78 17.0%25Insider Trade5.85%TWSTTwist Bioscience$119.20-4.9%1.3595 of 5 stars2.70$98.30 -17.5%10Insider Trade5.10%NTRANatera$309.31-0.5%2.6901 of 5 stars2.82$319.38 3.3%22Analyst Forecast5.06%TXG10x Genomics$56.58-2.7%1.7203 of 5 stars2.25$38.31 -32.3%16Analyst ForecastInsider Trade4.74%ILMNIllumina$191.14-0.8%3.235 of 5 stars2.47$188.40 -1.4%17Positive News4.06%TECHBio-Techne$72.40+0.3%3.196 of 5 stars2.06$68.92 -4.8%17Earnings ReportDividend AnnouncementAnalyst Downgrade3.90%ARWRArrowhead Pharmaceuticals$86.87+1.5%2.0281 of 5 stars2.62$97.33 12.1%133.88%BMRNBioMarin Pharmaceutical$67.44-1.6%4.8586 of 5 stars2.70$88.00 30.5%23Analyst Downgrade3.73%VRTXVertex Pharmaceuticals$505.83-2.1%4.4256 of 5 stars2.92$563.50 11.4%243.52%PRAXPraxis Precision Medicines$364.14-1.2%3.252 of 5 stars3.00$573.05 57.4%22Analyst Revision3.50%MRNAModerna$62.85-1.3%1.3524 of 5 stars1.88$42.13 -33.0%173.48%QGENQiagen$42.84-0.9%3.5568 of 5 stars2.36$43.93 2.5%14Options Volume3.16%VCYTVeracyte$41.65-2.2%4.4681 of 5 stars2.82$54.33 30.5%11Positive NewsAnalyst Upgrade3.12%CRSPCRISPR Therapeutics$53.20-1.5%3.6184 of 5 stars2.58$68.06 27.9%192.84%BNTXBioNTech$92.98+0.9%3.3454 of 5 stars2.74$127.81 37.5%192.63%LEGNLegend Biotech$20.26-0.1%3.0824 of 5 stars2.47$52.29 158.1%15News CoverageEarnings ReportAnalyst Forecast2.35%CAICaris Life Sciences$21.72-2.1%4.3407 of 5 stars2.50$26.33 21.3%122.21%QUREuniQure$47.72+1.4%3.2403 of 5 stars2.71$65.00 36.2%17Positive News2.20%BEAMBeam Therapeutics$26.510.0%1.7692 of 5 stars2.69$49.00 84.8%13Analyst Revision2.10%LLYEli Lilly and Company$1,179.81-2.4%4.732 of 5 stars2.83$1,292.18 9.5%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision2.08%RAREUltragenyx Pharmaceutical$26.31-0.3%3.1681 of 5 stars2.83$57.82 119.8%18Analyst Revision1.84%CDNACareDx$45.42-4.1%3.5269 of 5 stars2.43$47.75 5.1%71.71%WGSGeneDx$77.87-1.6%3.5964 of 5 stars2.67$89.57 15.0%91.65%GILDGilead Sciences$138.18+0.0%4.4525 of 5 stars2.83$158.04 14.4%29Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision This page (NASDAQ:GNOM) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...Decentralized Masters | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredAfter KDA, PRE, and OCEAN—this is the one17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
